-
1
-
-
0001554579
-
Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions, a report of the conclusions of a Ciba guest symposium
-
Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions, a report of the conclusions of a Ciba guest symposium. Thorax 1959; 14: 286-299.
-
(1959)
Thorax
, vol.14
, pp. 286-299
-
-
-
2
-
-
0000225183
-
Committee on diagnostic standards for non tuberculous respiratory diseases: Chronic bronchitis, asthma, and pulmonary emphysema
-
American Thoracic Society
-
American Thoracic Society. Committee on diagnostic standards for non tuberculous respiratory diseases: chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 1962; 85: 762-768.
-
(1962)
Am Rev Respir Dis
, vol.85
, pp. 762-768
-
-
-
3
-
-
0022359956
-
The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables
-
Eliasson O, Degraff AC Jr. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. Am Rev Respir Dis 1985; 132: 858-864.
-
(1985)
Am Rev Respir Dis
, vol.132
, pp. 858-864
-
-
Eliasson, O.1
Degraff Jr., A.C.2
-
4
-
-
0022625717
-
Bronchodilator response in chronic obstructive pulmonary disease
-
the IPPB trial group
-
Anthonisen NR, Wright EC, the IPPB trial group, Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 814-819.
-
(1986)
Am Rev Respir Dis
, vol.133
, pp. 814-819
-
-
Anthonisen, N.R.1
Wright, E.C.2
-
6
-
-
24644496531
-
Interpretative strategies for lung function tests
-
DOI 10.1183/09031936.05.00035205
-
Pellegrino RC, Viegi G, Brusasco V, et al. Interpretive strategies for lung function tests. Eur Respir J 2005; 26: 948-968. (Pubitemid 41632054)
-
(2005)
European Respiratory Journal
, vol.26
, Issue.5
, pp. 948-968
-
-
Pellegrino, R.1
Viegi, G.2
Brusasco, V.3
Crapo, R.O.4
Burgos, F.5
Casaburi, R.6
Coates, A.7
Van Der Grinten, C.P.M.8
Gustafsson, P.9
Hankinson, J.10
Jensen, R.11
Johnson, D.C.12
MacIntyre, N.13
McKay, R.14
Miller, M.R.15
Navajas, D.16
Pedersen, O.F.17
Wanger, J.18
-
7
-
-
1542405163
-
Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care
-
Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59: Suppl. I, 1-232.
-
(2004)
Thorax
, vol.59
, Issue.SUPPL. I
, pp. 1-232
-
-
-
8
-
-
0032253550
-
Assessing the reversibility of airway obstruction
-
Pellegrino R, Rodarte JR, Brusasco V. Assessing the reversibility of airway obstruction. Chest 1998; 114: 1607-1612.
-
(1998)
Chest
, vol.114
, pp. 1607-1612
-
-
Pellegrino, R.1
Rodarte, J.R.2
Brusasco, V.3
-
9
-
-
2442555774
-
Assessment of emphysema in COPD: A functional and radiologic study
-
DOI 10.1378/chest.125.5.1714
-
Cerveri I, Dore R, Corsico A, et al. Assessment of emphysema in COPD: a functional and radiological study. Chest 2004; 125: 1714-1718. (Pubitemid 38648402)
-
(2004)
Chest
, vol.125
, Issue.5
, pp. 1714-1718
-
-
Cerveri, I.1
Dore, R.2
Corsico, A.3
Zoia, M.C.4
Pellegrino, R.5
Brusasco, V.6
Pozzi, E.7
-
10
-
-
77951950812
-
Prevalence and clinical correlates of bronchoreversibility in severe emphysema
-
Han MK, Wise R, Mumford J, et al. Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J 2010; 35: 1048-1056.
-
(2010)
Eur Respir J
, vol.35
, pp. 1048-1056
-
-
Han, M.K.1
Wise, R.2
Mumford, J.3
-
11
-
-
0020415988
-
Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema
-
Hughes JA, Tobin MJ, Bellamy D, et al. Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema. Thorax 1982; 37: 667-670. (Pubitemid 13243955)
-
(1982)
Thorax
, vol.37
, Issue.9
, pp. 667-670
-
-
Hughes, J.A.1
Tobin, M.J.2
Bellamy, D.3
Hutchison, D.C.S.4
-
12
-
-
0030971611
-
Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function
-
Martinez F, Montes de Oca M, Whyte R, et al. Lung volume reduction improves dyspnea, dynamic hyperinflation and respiratory muscle function. Am J Respir Crit Care Med 1997; 155: 1984-1990. (Pubitemid 27256129)
-
(1997)
American Journal of Respiratory and Critical Care Medicine
, vol.155
, Issue.6
, pp. 1984-1990
-
-
Martinez, F.J.1
De Oca, M.M.2
Whyte, R.I.3
Stetz, J.4
Gay, S.E.5
Celli, B.R.6
-
13
-
-
0032778472
-
Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease
-
O'Donnell D, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 542-549. (Pubitemid 29380670)
-
(1999)
American Journal of Respiratory and Critical Care Medicine
, vol.160
, Issue.2
, pp. 542-549
-
-
O'Donnell, D.E.1
Lam, M.2
Webb, K.A.3
-
14
-
-
0041853629
-
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
-
DOI 10.1136/thorax.58.8.659
-
Calverley PM, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-664. (Pubitemid 36976273)
-
(2003)
Thorax
, vol.58
, Issue.8
, pp. 659-664
-
-
Calverley, P.M.A.1
Burge, P.S.2
Spencer, S.3
Anderson, J.A.4
Jones, P.W.5
-
15
-
-
42949152368
-
Bronchodilator responsiveness in patients with COPD
-
Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31: 742-750.
-
(2008)
Eur Respir J
, vol.31
, pp. 742-750
-
-
Tashkin, D.P.1
Celli, B.2
Decramer, M.3
-
16
-
-
0034643610
-
Randomized, double-blind, placebo controlled study on fluticasone propionate, in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
-
Burge PS, Calverley PM, Jones PW, et al. Randomized, double-blind, placebo controlled study on fluticasone propionate, in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 297-303.
-
(2000)
BMJ
, vol.320
, pp. 297-303
-
-
Burge, P.S.1
Calverley, P.M.2
Jones, P.W.3
-
17
-
-
0034727828
-
Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
-
The Lung Health Study Research Group
-
The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1902-1909.
-
(2000)
N Engl J Med
, vol.343
, pp. 1902-1909
-
-
-
18
-
-
0033614639
-
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
-
DOI 10.1016/S0140-6736(98)10019-3
-
Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353: 1819-1823. (Pubitemid 29251012)
-
(1999)
Lancet
, vol.353
, Issue.9167
, pp. 1819-1823
-
-
Vestbo, J.1
Sorensen, T.2
Lange, P.3
Brix, A.4
Tone, P.5
Viskum, K.6
-
19
-
-
0345188819
-
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
-
DOI 10.1056/NEJM199906243402503
-
Pauwels RA, Löfdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999; 340: 1948-1953. (Pubitemid 29288270)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.25
, pp. 1948-1953
-
-
Pauwels, R.A.1
Lofdahl, C.-G.2
Laitinen, L.A.3
Schouten, J.P.4
Postma, D.S.5
Pride, N.B.6
Ohlsson, S.V.7
-
20
-
-
0037425745
-
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial
-
DOI 10.1016/S0140-6736(03)12459-2
-
Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2003; 361: 449-456. (Pubitemid 36173708)
-
(2003)
Lancet
, vol.361
, Issue.9356
, pp. 449-456
-
-
Calverley, P.1
Pauwels, R.2
Vestbo, J.3
Jones, P.4
Pride, N.5
Gulsvik, A.6
Anderson, J.7
Maden, C.8
-
21
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-1554.
-
(2008)
N Engl J Med
, vol.359
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
22
-
-
69249125783
-
Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD
-
Dellacà RL, Pompilio PP, Walker PPP, et al. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD. Eur Respir J 2009; 33: 1329-1339.
-
(2009)
Eur Respir J
, vol.33
, pp. 1329-1339
-
-
Dellacà, R.L.1
Pompilio, P.P.2
Walker, P.P.P.3
-
23
-
-
34247561439
-
Tiotropium in combination with placebo, salmeterol, or fluticasone- Salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial
-
Aaron SD, Vandemheen KL, Fergusson D, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007; 146: 545-555. (Pubitemid 351650535)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.8
, pp. 545-555
-
-
Aaron, S.D.1
Vandemheen, K.L.2
Fergusson, D.3
Maltais, F.4
Bourbeau, J.5
Goldstein, R.6
Balter, M.7
O'Donnell, D.8
McIvor, A.9
Sharma, S.10
Bishop, G.11
Anthony, J.12
Cowie, R.13
Field, S.14
Hirsch, A.15
Hernandez, P.16
Rivington, R.17
Road, J.18
Hoffstein, V.19
Hodder, R.20
Marciniuk, D.21
McCormack, D.22
Fox, G.23
Cox, G.24
Prins, H.B.25
Ford, G.26
Bleskie, D.27
Doucette, S.28
Mayers, I.29
Chapman, K.30
Zamel, N.31
Fitzgerald, M.32
more..
-
24
-
-
70349854706
-
Efficacy and tolerability of budenoside/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseases
-
Welte T, Miratvilles M, Hernandez P, et al. Efficacy and tolerability of budenoside/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseases. Am J Respir Crit Care Med 2009; 180: 741-750.
-
(2009)
Am J Respir Crit Care Med
, vol.180
, pp. 741-750
-
-
Welte, T.1
Miratvilles, M.2
Hernandez, P.3
|